Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P, Suojaranta-Ylinen R, Kuitunen AH
Ann Thorac Surg 2005;80(1):66-71.
Review by M. Aldouri
Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Despotis G, Avidan M, Lublin DM, et al.
Ann Thorac Surg 2005;80(1):3-5.
Review by M. Aldouri
Successful use of one dose of recombinant factor VIIa to control severe bleeding after emergency aortic arch replacement in deep hypothermic circulatory arrest.
Wiesenack C, Arlt M, Liebold A, Schmid FX
J Thorac Cardiovasc Surg 2004;128(6):941-943.
Review by
Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin.
McIlroy DR, Silvers AJ
Anesth Analg 2004;99:27-30.
Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
Koster A, Huebler S, Merkle F, et al.
Anesth Analg 2004;98:285-90.
The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery.
Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M
Ann Thorac Surg 2003;76(3):784-791.
Review by
Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery.
Covin R, OBrien M, Grunwald G, et al.
Arch Pathol Lab Med 2003;127(4):415-423.
Review by Kretschmer V
Does priming implementation with low-dose albumin reduce postoperative bleeding following cardiopulmonary bypass?
Onorati F, Santarpino G, Renzulli A, et al.
Int J Artif Organs 2003;26(3):211-216.
Review by Mythen MG
Blood use in patients undergoing coronary artery bypass surgery: impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight.
Scott BH, Seifert FC, Glass PS, Grimson R
Anesth Analg 2003;97:958-963.
Review by Kretschmer V
Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study.
Spahn DR, Waschke KF, Standl T, et al.
Anesthesiology 2002;97(6):1338-1349.
Review by
Autologous blood sequestration using a double venous reservoir bypass circuit and polymerized hemoglobin prime.
Neragi-Miandoab S, Guerrero JL, Vlahakes GJ
ASAIO J 2002;48(4):407-411.
Review by Van der Linden P
Intraoperative low-volume acute normovolemic hemodilution in adult open-heart surgery.
Casati V, Speziali G, D’Alessandro C, et al.
Anesthesiology 2002;97(2):367-373.
Review by Van der Linden P***; Messmer K****
Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery.
Balachandran S, Cross MH, Karthikeyan S, Mulpur A, Hansbro SD, Hobson P
Ann Thorac Surg 2002;73(6):1912-1918.
Review by Van der Linden P
Are lactated Ringer’s solution and normal saline solution equal with regard to coagulation?
This study compares the perioperative effects of a saline crystalloid and a more balanced and buffered electrolyte crystalloid on clotting. The differences thought to be... Read More
Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic, effect.
Molenaar IQ, Legnani C, Groenland TH, et al.
Liver Transplant 2001;7(10):896-903.
Review by W. Dietrich
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659